FDA Inspection
The Magni Group, Inc.The Magni Group, Inc. – FDA Inspection, Feb 7, 2018
Record Details
This FDA Inspection record concerns The Magni Group, Inc., with an inspection on February 7, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c52675c9-6806-481e-b472-9d1fe53cd095
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1041303
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.198(a)Procedures to be written and followed
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of The Magni Group, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2023 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| January 29, 2015 | OAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
Other documents for The Magni Group, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.